Oral complications of targeted cancer therapies: A narrative literature review
- Author
- WATTERS, A. L1 ; EPSTEIN, J. B2 3 ; AGULNIK, M4
[1] Department of Oral and Maxillofacial Pathology, Radiology and Medicine, New York University, College of Dentistry, New York, NY, United States
[2] Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois, Chicago, IL, United States
[3] Department of Otolaryngology and Head and Neck Surgery and Cancer Center, College of Medicine, University of Illinois, Chicago, IL, United States
[4] Northwestern University, Feinberg School of Medicine, Division of Hematology/Oncology, Department of Medicine, Chicago, IL, United States - Source
Oral oncology (1997). 2011, Vol 47, Num 6, pp 441-448, 8 p ; ref : 143 ref
- ISSN
- 1368-8375
- Scientific domain
- Medical oncology; Otorhinolaryngology, stomatology, dentistry
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Cetuximab Dental complications Epidermal growth factor receptor inhibitor Erbitux Erlotinib Head and neck cancer Monoclonal antibody therapy Mucositis Nexavar Oral adverse events Oral cancer Oral complications Oral side effects Oral toxicities Panitumumab Small molecule inhibitors Sorafenib Stomatitis Sunitinib malate Sutent Tarceva Targeted cancer therapy Tyrosine kinase inhibitors Vectibix
- Keyword (fr)
- Antiangiogénique Anticancéreux Anticorps monoclonal Cancer de la cavité buccale Cancer de la tête et du cou Cancérologie Complication Cétuximab Dent Erlotinib Facteur croissance épiderme Immunomodulateur Inhibiteur de la tyrosine kinase Narration ORL Panitumumab Revue bibliographique Récepteur facteur croissance Sorafénib Stomatite Stomatologie Sunitinib Thérapeutique ciblée Toxicité Traitement Tumeur maligne Voie orale Anti-EGFR Mucite Cancer Dérivé de la quinazoline Enzyme Inhibiteur enzyme Inhibiteur multikinase Pathologie ORL Pathologie de la cavité buccale Protein-tyrosine kinase Récepteur facteur croissance épiderme Transferases
- Keyword (en)
- Antiangiogenic agent Antineoplastic agent Monoclonal antibody Oral cancer Head and neck cancer Cancerology Complication Cetuximab Tooth Erlotinib Epidermal growth factor Immunomodulator Tyrosine kinase inhibitor Narrative ENT Panitumumab Bibliographic review Growth factor receptor Sorafenib Stomatitis Stomatology Sunitinib Targeted therapy Toxicity Treatment Malignant tumor Oral administration Mucositis Cancer Quinazoline derivatives Enzyme Enzyme inhibitor Multikinase inhibitor ENT disease Oral cavity disease Protein-tyrosine kinase Epidermal growth factor receptor Transferases
- Keyword (es)
- Antiangiogenico Anticanceroso Anticuerpo monoclonal Cáncer de cavidad bucal Cáncer de cabeza y cuello Cancerología Complicación Cetuximab Diente Erlotinib Factor de crecimiento epidérmico Inmunomodulador Inhibidor tyrosine kinase Narración ORL Panitumumab Revista bibliográfica Receptor factor crecimiento Sorafenib Estomatitis Estomatología Sunitinib Terapéutica dirigida Toxicidad Tratamiento Tumor maligno Vía oral Cáncer Enzima Inhibidor enzima inhibidor multicinasa ORL patología Cavidad bucal patología Protein-tyrosine kinase Receptor del factor de crecimiento epidérmico Transferases
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10B Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology / 002B10B01 Tumors
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10C Facial bones, jaws, teeth, parodontium: diseases, semeiology / 002B10C02 Non tumoral diseases
- Discipline
- Otorhinolaryngology. Stomatology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 24272673
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.oraloncology.2011.03.028 
https://dx.doi.org/10.1016/j.oraloncology.2011.03.028
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1016\/j.oraloncology.2011.03.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Oral oncology (1997)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Oral oncol. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"441\";s:8:\"\u0000*\u0000epage\";s:3:\"448\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-8375\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WATTERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"EPSTEIN, J. B\";i:1;s:10:\"AGULNIK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1016\/j.oraloncology.2011.03.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Oral oncology (1997)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Oral oncol. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"441\";s:8:\"\u0000*\u0000epage\";s:3:\"448\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-8375\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WATTERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"EPSTEIN, J. B\";i:1;s:10:\"AGULNIK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1016\/j.oraloncology.2011.03.028\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1016\/j.oraloncology.2011.03.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Oral oncology (1997)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Oral oncol. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"441\";s:8:\"\u0000*\u0000epage\";s:3:\"448\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-8375\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WATTERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"EPSTEIN, J. B\";i:1;s:10:\"AGULNIK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1016\/j.oraloncology.2011.03.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Oral oncology (1997)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Oral oncol. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"441\";s:8:\"\u0000*\u0000epage\";s:3:\"448\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-8375\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WATTERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"EPSTEIN, J. B\";i:1;s:10:\"AGULNIK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1016\/j.oraloncology.2011.03.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Oral oncology (1997)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Oral oncol. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"441\";s:8:\"\u0000*\u0000epage\";s:3:\"448\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-8375\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WATTERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"EPSTEIN, J. B\";i:1;s:10:\"AGULNIK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Oral complications of targeted cancer therapies: A narrative literature review\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
